Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica N McAlpine

Showing results (101-110 of 186) with videos related to

Pageof 19
Sort By:
Gynecologic Oncology|April 14, 2016
Progesterone receptor expression is associated with longer overall survival within high-grade histotypes of endometrial carcinoma: A Canadian high risk endometrial cancer consortium (CHREC) studyMartin Köbel, Eshetu G Atenafu, Peter F Rambau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 25, 2010
Tumor growth inhibition by olaparib in BRCA2 germline-mutated patient-derived ovarian cancer tissue xenograftsUrsula Kortmann, Jessica N McAlpine, Hui Xue, et al.
The Journal of Pathology|July 6, 2017
Clear cell and endometrioid carcinomas: are their differences attributable to distinct cells of origin?Dawn R Cochrane, Basile Tessier-Cloutier, Katherine M Lawrence, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|October 28, 2022
Data Set for the Reporting of Carcinomas of the Vulva: Recommendations From the International Collaboration on Cancer Reporting (ICCR)Lynn Hoang, Fleur Webster, Tjalling Bosse, et al.
Gynecologic Oncology|March 30, 2019
Molecular classification defines outcomes and opportunities in young women with endometrial carcinomaHeidi Britton, Leo Huang, Amy Lum, et al.
The Journal of Pathology. Clinical Research|November 1, 2017
Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classificationAnthony N Karnezis, Samuel Leung, Jamie Magrill, et al.
The Journal of Pathology. Clinical Research|August 9, 2016
In-depth molecular profiling of the biphasic components of uterine carcinosarcomasMelissa K McConechy, Lien N Hoang, Michael Herman Chui, et al.
Gynecologic Oncology|January 27, 2026
Substratification of mismatch repair deficient endometrial cancers based on mechanism of MMR loss can provide prognostic and predictive refinementAmy Jamieson, Sila Rogan, Allen W Zhang, et al.
Cancers|January 8, 2025
Molecular Subtypes of Vulvar Squamous Cell Carcinoma: The Significance of HPV-Independent/p53 Wild TypeLars-Christian Horn, Christine E Brambs, Blake Gilks, et al.
Plos One|October 14, 2020
Establishment and characterization of VOA1066 cells: An undifferentiated endometrial carcinoma cell lineYemin Wang, Valerie Lan Tao, Chae Young Shin, et al.
Pageof 19

Showing results (101-110 of 186) with videos related to

Sort By:
Pageof 19
Gynecologic Oncology|April 14, 2016
Progesterone receptor expression is associated with longer overall survival within high-grade histotypes of endometrial carcinoma: A Canadian high risk endometrial cancer consortium (CHREC) studyMartin Köbel, Eshetu G Atenafu, Peter F Rambau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 25, 2010
Tumor growth inhibition by olaparib in BRCA2 germline-mutated patient-derived ovarian cancer tissue xenograftsUrsula Kortmann, Jessica N McAlpine, Hui Xue, et al.
The Journal of Pathology|July 6, 2017
Clear cell and endometrioid carcinomas: are their differences attributable to distinct cells of origin?Dawn R Cochrane, Basile Tessier-Cloutier, Katherine M Lawrence, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|October 28, 2022
Data Set for the Reporting of Carcinomas of the Vulva: Recommendations From the International Collaboration on Cancer Reporting (ICCR)Lynn Hoang, Fleur Webster, Tjalling Bosse, et al.
Gynecologic Oncology|March 30, 2019
Molecular classification defines outcomes and opportunities in young women with endometrial carcinomaHeidi Britton, Leo Huang, Amy Lum, et al.
The Journal of Pathology. Clinical Research|November 1, 2017
Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classificationAnthony N Karnezis, Samuel Leung, Jamie Magrill, et al.
The Journal of Pathology. Clinical Research|August 9, 2016
In-depth molecular profiling of the biphasic components of uterine carcinosarcomasMelissa K McConechy, Lien N Hoang, Michael Herman Chui, et al.
Gynecologic Oncology|January 27, 2026
Substratification of mismatch repair deficient endometrial cancers based on mechanism of MMR loss can provide prognostic and predictive refinementAmy Jamieson, Sila Rogan, Allen W Zhang, et al.
Cancers|January 8, 2025
Molecular Subtypes of Vulvar Squamous Cell Carcinoma: The Significance of HPV-Independent/p53 Wild TypeLars-Christian Horn, Christine E Brambs, Blake Gilks, et al.
Plos One|October 14, 2020
Establishment and characterization of VOA1066 cells: An undifferentiated endometrial carcinoma cell lineYemin Wang, Valerie Lan Tao, Chae Young Shin, et al.
Pageof 19